230 related articles for article (PubMed ID: 34281217)
1. Muricholic Acids Promote Resistance to Hypercholesterolemia in Cholesterol-Fed Mice.
Gaillard D; Masson D; Garo E; Souidi M; Pais de Barros JP; Schoonjans K; Grober J; Besnard P; Thomas C
Int J Mol Sci; 2021 Jul; 22(13):. PubMed ID: 34281217
[TBL] [Abstract][Full Text] [Related]
2. Protective effects of farnesoid X receptor (FXR) on hepatic lipid accumulation are mediated by hepatic FXR and independent of intestinal FGF15 signal.
Schmitt J; Kong B; Stieger B; Tschopp O; Schultze SM; Rau M; Weber A; Müllhaupt B; Guo GL; Geier A
Liver Int; 2015 Apr; 35(4):1133-1144. PubMed ID: 25156247
[TBL] [Abstract][Full Text] [Related]
3. Intestine-specific deletion of SIRT1 in mice impairs DCoH2-HNF-1α-FXR signaling and alters systemic bile acid homeostasis.
Kazgan N; Metukuri MR; Purushotham A; Lu J; Rao A; Lee S; Pratt-Hyatt M; Lickteig A; Csanaky IL; Zhao Y; Dawson PA; Li X
Gastroenterology; 2014 Apr; 146(4):1006-16. PubMed ID: 24389307
[TBL] [Abstract][Full Text] [Related]
4. Lactobacillus plantarum LRCC 5273 isolated from Kimchi ameliorates diet-induced hypercholesterolemia in C57BL/6 mice.
Heo W; Lee ES; Cho HT; Kim JH; Lee JH; Yoon SM; Kwon HT; Yang S; Kim YJ
Biosci Biotechnol Biochem; 2018 Nov; 82(11):1964-1972. PubMed ID: 30032716
[TBL] [Abstract][Full Text] [Related]
5. Atorvastatin protects against liver and vascular damage in a model of diet induced steatohepatitis by resetting FXR and GPBAR1 signaling.
Marchianò S; Biagioli M; Roselli R; Zampella A; Di Giorgio C; Bordoni M; Bellini R; Morretta E; Monti MC; Distrutti E; Fiorucci S
FASEB J; 2022 Jan; 36(1):e22060. PubMed ID: 34862975
[TBL] [Abstract][Full Text] [Related]
6. Medium-chain fatty acids reduce serum cholesterol by regulating the metabolism of bile acid in C57BL/6J mice.
Liu Y; Zhang Y; Zhang X; Xu Q; Yang X; Xue C
Food Funct; 2017 Jan; 8(1):291-298. PubMed ID: 28009872
[TBL] [Abstract][Full Text] [Related]
7. Impact of Inhibiting Ileal Apical versus Basolateral Bile Acid Transport on Cholesterol Metabolism and Atherosclerosis in Mice.
Dawson PA
Dig Dis; 2015; 33(3):382-7. PubMed ID: 26045273
[TBL] [Abstract][Full Text] [Related]
8. Hepatic overexpression of abcb11 promotes hypercholesterolemia and obesity in mice.
Henkel AS; Kavesh MH; Kriss MS; Dewey AM; Rinella ME; Green RM
Gastroenterology; 2011 Oct; 141(4):1404-11, 1411.e1-2. PubMed ID: 21726512
[TBL] [Abstract][Full Text] [Related]
9. Dietary cholesterol drives the development of nonalcoholic steatohepatitis by altering gut microbiota mediated bile acid metabolism in high-fat diet fed mice.
Gao X; Lin X; Xin Y; Zhu X; Li X; Chen M; Huang Z; Guo H
J Nutr Biochem; 2023 Jul; 117():109347. PubMed ID: 37031879
[TBL] [Abstract][Full Text] [Related]
10. Cyp7a1 is continuously increased with disrupted Fxr-mediated feedback inhibition in hypercholesterolemic TALLYHO/Jng mice.
Lee EA; Lee DI; Kim HY; Ahn SH; Seong HR; Jung WH; Kim KY; Kim S; Rhee SD
Biochim Biophys Acta Mol Cell Biol Lipids; 2018 Jan; 1863(1):20-25. PubMed ID: 28843503
[TBL] [Abstract][Full Text] [Related]
11. Studies on LXR- and FXR-mediated effects on cholesterol homeostasis in normal and cholic acid-depleted mice.
Wang J; Einarsson C; Murphy C; Parini P; Björkhem I; Gåfvels M; Eggertsen G
J Lipid Res; 2006 Feb; 47(2):421-30. PubMed ID: 16264196
[TBL] [Abstract][Full Text] [Related]
12. Cholesterol-lowering effects of taurine through the reduction of ileal FXR signaling due to the alteration of ileal bile acid composition.
Miyata M; Tanaka T; Takahashi K; Funaki A; Sugiura Y
Amino Acids; 2021 Oct; 53(10):1523-1532. PubMed ID: 34596761
[TBL] [Abstract][Full Text] [Related]
13. Small Heterodimer Partner and Fibroblast Growth Factor 19 Inhibit Expression of NPC1L1 in Mouse Intestine and Cholesterol Absorption.
Kim YC; Byun S; Seok S; Guo G; Xu HE; Kemper B; Kemper JK
Gastroenterology; 2019 Mar; 156(4):1052-1065. PubMed ID: 30521806
[TBL] [Abstract][Full Text] [Related]
14. Influence of cholesterol feeding on bile acid metabolism in young and aged germ-free rats.
Uchida K; Satoh T; Chikai T; Takase H; Nomura Y; Nakao H; Takeuchi N
Jpn J Pharmacol; 1996 Jun; 71(2):113-8. PubMed ID: 8835637
[TBL] [Abstract][Full Text] [Related]
15. FXR-dependent reduction of hepatic steatosis in a bile salt deficient mouse model.
Kunne C; Acco A; Duijst S; de Waart DR; Paulusma CC; Gaemers I; Oude Elferink RP
Biochim Biophys Acta; 2014 May; 1842(5):739-46. PubMed ID: 24548803
[TBL] [Abstract][Full Text] [Related]
16. Identification of a novel function of hepatic long-chain acyl-CoA synthetase-1 (ACSL1) in bile acid synthesis and its regulation by bile acid-activated farnesoid X receptor.
Singh AB; Dong B; Xu Y; Zhang Y; Liu J
Biochim Biophys Acta Mol Cell Biol Lipids; 2019 Mar; 1864(3):358-371. PubMed ID: 30580099
[TBL] [Abstract][Full Text] [Related]
17. Geniposide reduces cholesterol accumulation and increases its excretion by regulating the FXR-mediated liver-gut crosstalk of bile acids.
Liu J; Li Y; Sun C; Liu S; Yan Y; Pan H; Fan M; Xue L; Nie C; Zhang H; Qian H; Ying H; Wang L
Pharmacol Res; 2020 Feb; 152():104631. PubMed ID: 31911244
[TBL] [Abstract][Full Text] [Related]
18. Gut microbiota regulates bile acid metabolism by reducing the levels of tauro-beta-muricholic acid, a naturally occurring FXR antagonist.
Sayin SI; Wahlström A; Felin J; Jäntti S; Marschall HU; Bamberg K; Angelin B; Hyötyläinen T; Orešič M; Bäckhed F
Cell Metab; 2013 Feb; 17(2):225-35. PubMed ID: 23395169
[TBL] [Abstract][Full Text] [Related]
19. The Diet1 locus confers protection against hypercholesterolemia through enhanced bile acid metabolism.
Phan J; Pesaran T; Davis RC; Reue K
J Biol Chem; 2002 Jan; 277(1):469-77. PubMed ID: 11682476
[TBL] [Abstract][Full Text] [Related]
20. Hepatic inflammation caused by dysregulated bile acid synthesis is reversible by butyrate supplementation.
Sheng L; Jena PK; Hu Y; Liu HX; Nagar N; Kalanetra KM; French SW; French SW; Mills DA; Wan YY
J Pathol; 2017 Dec; 243(4):431-441. PubMed ID: 28892150
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
